Direct oral anticoagulant and antiplatelet therapy for extracranial neurovascular stenting in patients with atrial fibrillation
Dual antithrombotic therapy (NOAC + P2Y12 inhibitor) post-procedure may balance efficacy and safety in NVAF patients undergoing CAS/VAS. Larger studies are needed for validation.
Authors
- Qingqing Gao (ORCID: https://orcid.org/0000-0002-2746-0352)
- Jinhua Zhang (ORCID: https://orcid.org/0000-0001-6103-7016)
- Feina Shi (ORCID: https://orcid.org/0000-0001-9855-5765)
- Yun Jiang (ORCID: https://orcid.org/0009-0003-3020-8574)
- Chuan Xu
- Zheng Xu (ORCID: https://orcid.org/0000-0003-2837-8067)
- Yigang Chen (ORCID: https://orcid.org/0000-0002-3036-3537)
Institutions
- Sir Run Run Shaw Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1186/s12883-025-04240-2
- Citations
- 1
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Sir Run Run Shaw Hospital
- Natural Science Foundation of Zhejiang Province
- Science and Technology Program of Zhejiang Province